发明授权
- 专利标题: MAPK/ERK kinase inhibitors
- 专利标题(中): MAPK / ERK激酶抑制剂
-
申请号: US11932615申请日: 2007-10-31
-
公开(公告)号: US07943659B2公开(公告)日: 2011-05-17
- 发明人: Mark E. Adams , Qing Dong , Michael B. Wallace
- 申请人: Mark E. Adams , Qing Dong , Michael B. Wallace
- 申请人地址: JP Osaka
- 专利权人: Takeda Pharmaceutical Company Limited
- 当前专利权人: Takeda Pharmaceutical Company Limited
- 当前专利权人地址: JP Osaka
- 代理商 David M. Stemerick; Mitchell R. Brustein
- 主分类号: A61K31/40
- IPC分类号: A61K31/40 ; C07D207/34
摘要:
Compounds, pharmaceutical compositions, kits and methods are provided for use with MEK that comprise a compound selected from the group consisting of: wherein the variables are as defined herein.
公开/授权文献
- US20080188453A1 MAPK/ERK KINASE INHIBITORS 公开/授权日:2008-08-07